Growth Metrics

Core Laboratories (CLB) Gains from Investment Securities (2022 - 2025)

Core Laboratories' Gains from Investment Securities history spans 4 years, with the latest figure at $170000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 86.68% year-over-year to $170000.0; the TTM value through Dec 2025 reached -$682000.0, down 166.86%, while the annual FY2025 figure was $894109.0, 1499.42% up from the prior year.
  • Gains from Investment Securities reached $170000.0 in Q4 2025 per CLB's latest filing, up from -$286000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.3 million in Q4 2024 to a low of -$917000.0 in Q1 2025.
  • Average Gains from Investment Securities over 4 years is -$10571.4, with a median of $35500.0 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: soared 1303.77% in 2024, then tumbled 340.68% in 2025.
  • A 4-year view of Gains from Investment Securities shows it stood at $436000.0 in 2022, then tumbled by 124.31% to -$106000.0 in 2023, then skyrocketed by 1303.77% to $1.3 million in 2024, then plummeted by 86.68% to $170000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLB's Gains from Investment Securities are $170000.0 (Q4 2025), -$286000.0 (Q3 2025), and $351000.0 (Q2 2025).